Eurofins Scientific SE (EPA:ERF)

Revenue Breakdown

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Sample-Based Business Revenue	6.13B	5.81B
Sample-Based Business Revenue Growth	5.46%	7.88%
Study-Based Business Revenue	522.30M	521.00M
Study-Based Business Revenue Growth	0.25%	-3.68%
FTE-Based Business Revenue	516.20M	477.80M
FTE-Based Business Revenue Growth	8.04%	6.46%
Product-Based Business Revenue	128.40M	138.90M
Product-Based Business Revenue Growth	-7.56%	1.39%
Other Service Line Revenue	-	1.40M
Other Service Line Revenue Growth	-	250.00%
Revenue (Total)	7.30B	6.95B
Revenue (Total) Growth	4.96%	6.70%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Europe Revenue	3.83B	3.55B
Europe Revenue Growth	7.89%	7.34%
North America Revenue	2.68B	2.66B
North America Revenue Growth	0.92%	6.11%
Rest of the World Revenue	782.30M	741.60M
Rest of the World Revenue Growth	5.49%	5.76%
Revenue (Total)	7.30B	6.95B
Revenue (Total) Growth	4.96%	6.70%

Revenue Breakdown 2

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Life Revenue	3.04B	2.87B
Life Revenue Growth	6.07%	10.05%
BioPharma Revenue	2.06B	2.01B
BioPharma Revenue Growth	2.59%	2.03%
Diagnostic Services & Products Revenue	1.50B	1.37B
Diagnostic Services & Products Revenue Growth	9.20%	7.37%
Consumer & Technology Products Testing Revenue	695.00M	702.00M
Consumer & Technology Products Testing Revenue Growth	-1.00%	6.20%
Revenue (Total)	7.30B	6.95B
Revenue (Total) Growth	4.96%	6.70%

EBITDA by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Europe EBITDA	667.60M	598.00M
Europe EBITDA Growth	11.64%	29.21%
North America EBITDA	747.90M	720.90M
North America EBITDA Growth	3.74%	10.14%
Rest of the World EBITDA	189.40M	161.40M
Rest of the World EBITDA Growth	17.35%	16.20%
Group Service Functions EBITDA	-43.90M	-40.90M
Operating Income (Total)	784.50M	680.50M
Operating Income (Total) Growth	15.28%	28.42%

Adjusted EBITDA by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Europe EBITAS	385.30M	332.50M
Europe EBITAS Growth	15.88%	63.87%
North America EBITAS	544.40M	531.70M
North America EBITAS Growth	2.39%	10.36%
Rest of the World EBITAS	111.80M	83.40M
Rest of the World EBITAS Growth	34.05%	28.90%
Group Service Functions EBITAS	-110.00M	-105.00M
Operating Income (Other)	-147.00M	-162.10M
Operating Income (Total)	784.50M	680.50M
Operating Income (Total) Growth	15.28%	28.42%

Net Income by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Europe Net Profit	286.80M	230.00M
Europe Net Profit Growth	24.70%	120.94%
North America Net Profit	385.00M	407.50M
North America Net Profit Growth	-5.52%	10.43%
Rest of the World Net Profit	71.00M	43.00M
Rest of the World Net Profit Growth	65.12%	59.26%
Group Service Functions Net Profit	-269.80M	-275.10M

Key Performance Indicators

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Europe - Organic Growth	3.30%	4.90%
North America - Organic Growth	2.80%	3.60%
Rest of the World - Organic Growth	9.00%	7.80%
Total Organic Growth	3.70%	4.70%

Data Source: Fiscal.ai Last updated: Jan 23, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 8, 2026

Data Sources Report a data error